HOYNE BANCORP INC (HYNE) Fundamental Analysis & Valuation

NASDAQ:HYNE • US44326H1077

Current stock price

15.83 USD
+0.37 (+2.39%)
Last:

This HYNE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HYNE Profitability Analysis

1.1 Basic Checks

  • HYNE had positive earnings in the past year.
  • In the past year HYNE had a positive cash flow from operations.
HYNE Yearly Net Income VS EBIT VS OCF VS FCFHYNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 2M -2M -4M -6M

1.2 Ratios

  • HYNE's Return On Assets of 0.10% is on the low side compared to the rest of the industry. HYNE is outperformed by 91.25% of its industry peers.
  • With a Return On Equity value of 0.29%, HYNE is not doing good in the industry: 91.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.1%
ROE 0.29%
ROIC N/A
ROA(3y)-0.04%
ROA(5y)N/A
ROE(3y)-0.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HYNE Yearly ROA, ROE, ROICHYNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • HYNE has a Profit Margin of 3.04%. This is amonst the worse of the industry: HYNE underperforms 91.25% of its industry peers.
  • The Operating Margin and Gross Margin are not available for HYNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3.04%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYNE Yearly Profit, Operating, Gross MarginsHYNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. HYNE Health Analysis

2.1 Basic Checks

  • HYNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HYNE has about the same amout of shares outstanding than it did 1 year ago.
  • There is no outstanding debt for HYNE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HYNE Yearly Shares OutstandingHYNE Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 2M 4M 6M 8M
HYNE Yearly Total Debt VS Total AssetsHYNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • HYNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC8.9%
HYNE Yearly LT Debt VS Equity VS FCFHYNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HYNE Yearly Current Assets VS Current LiabilitesHYNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. HYNE Growth Analysis

3.1 Past

  • HYNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 112.92%, which is quite impressive.
  • The Revenue has grown by 41.76% in the past year. This is a very strong growth!
EPS 1Y (TTM)112.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)41.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HYNE Yearly Revenue VS EstimatesHYNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 5M 10M 15M

More info and screens

Find the best growth stocksShow best growing peers

0

4. HYNE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 263.83, HYNE can be considered very expensive at the moment.
  • HYNE's Price/Earnings ratio is rather expensive when compared to the industry. HYNE is more expensive than 91.25% of the companies in the same industry.
  • HYNE is valuated expensively when we compare the Price/Earnings ratio to 27.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 263.83
Fwd PE N/A
HYNE Price Earnings VS Forward Price EarningsHYNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HYNE indicates a rather expensive valuation: HYNE more expensive than 85.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 88.61
EV/EBITDA N/A
HYNE Per share dataHYNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HYNE Dividend Analysis

5.1 Amount

  • HYNE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HYNE Fundamentals: All Metrics, Ratios and Statistics

HOYNE BANCORP INC

NASDAQ:HYNE (4/17/2026, 8:19:31 PM)

15.83

+0.37 (+2.39%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)03-26
Earnings (Next)N/A
Inst Owners12.86%
Inst Owner Change0%
Ins Owners1.11%
Ins Owner Change100%
Market Cap128.22M
Revenue(TTM)15.30M
Net Income(TTM)465.40K
AnalystsN/A
Price TargetN/A
Short Float %3.05%
Short Ratio5.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 263.83
Fwd PE N/A
P/S 8.38
P/FCF 88.61
P/OCF 51.49
P/B 0.79
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)0.06
EY0.38%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.18
FCFY1.13%
OCF(TTM)0.31
OCFY1.94%
SpS1.89
BVpS19.92
TBVpS19.9
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.18597 (-67.24%)
Profitability
Industry RankSector Rank
ROA 0.1%
ROE 0.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.04%
GM N/A
FCFM 9.46%
ROA(3y)-0.04%
ROA(5y)N/A
ROE(3y)-0.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 126.05%
Cap/Sales 6.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 310.94%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)118.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.36%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)41.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y144.88%
OCF growth 3YN/A
OCF growth 5YN/A

HOYNE BANCORP INC / HYNE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HOYNE BANCORP INC (HYNE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to HYNE.


Can you provide the valuation status for HOYNE BANCORP INC?

ChartMill assigns a valuation rating of 0 / 10 to HOYNE BANCORP INC (HYNE). This can be considered as Overvalued.


What is the profitability of HYNE stock?

HOYNE BANCORP INC (HYNE) has a profitability rating of 1 / 10.


Can you provide the PE and PB ratios for HYNE stock?

The Price/Earnings (PE) ratio for HOYNE BANCORP INC (HYNE) is 263.83 and the Price/Book (PB) ratio is 0.79.


What is the financial health of HOYNE BANCORP INC (HYNE) stock?

The financial health rating of HOYNE BANCORP INC (HYNE) is 4 / 10.